GENNEX LABORATORIES LTD. (GENNEX)

BSE: ₹10.89
Stock Performance
Corporate Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication

Pursuant to Regulation 47 of SEBI (LODR) Regulations, 2015, please find enclosed herewith Newspaper publication on Audited (Standalone and Consolidated) Financial Results for the Quarter and year ended March 31, 2026, announced by the Board of Directors in its meeting held on May 30, 2026. Financial Results had been published in both Business Standard (English) and Saksham (Telugu-Local) on June 01, 2026. We request you to take the above information on record and acknowledge receipt of the same.

2026-06-01 15:24:12
Financial Result For The Quarter And Year Ended March 31, 2026

In just concluded Meeting of Board of Directors, the Board approved and considered the following items: 1. Audited Standalone & Consolidated Financial Results for the Quarter and Year ended March 31, 2026. 2. Auditor's Report on audited Standalone and Consolidated Financial Statements for the Quarter and Year ended March 31, 2026, issued on dated May 30, 2026 along with the Statement on Impact of Audit Qualification (Standalone and Consolidated) are attached herewith. We hereby submit that the Board Meeting had commenced at 4:00 pm and concluded at 7:30 pm. This intimation is also uploaded on the company website www.gennexlab.com

2026-05-30 19:58:11
Board Meeting Outcome for Meeting Held On Today I.E. 30Th May 2026

In just concluded Meeting of Board of Directors, the Board Approved and considered the following items: 1. Audited Standalone & Consolidated Financial results for the Quarter & Year Ended March 31, 2026; 2. Auditor's Report on audited Standalone & Consolidated Financial Statements for the Quarter and Year ended March 31, 2026, issued on dated May 30, 2026 along with the Statement on Impact of Audit Qualification (Standalone & Consolidated) are attached herewith - Annexure I; We hereby submit that the Board Meeting had commenced at 4:00 PM and concluded at 7.30 PM. This intimation is also uploaded on the Company website: www.gennexlab.com. We request you to take the above information on record and acknowledge the receipt of the same.

2026-05-30 19:44:19
Compliances-Reg.24(A)-Annual Secretarial Compliance

In compliance with Regulation 24A of SEBI (LODR) Regulations, 2015, Board appointed M/s. Mohammed Tausif Shamim & Co., practicing Company Secretary, Kolkata as Secretarial Auditor of the Company for the Financial Year ended March 31, 2026. They carried out the Secretarial Audit and submitted the Annual Secretarial Compliance Report with reference to the SEBI circular 27/2019, dated 8th February 2019. We hereby submit the Annual Secretarial Compliance Report issued by the Secretarial Auditor within the timeline allowed by SEBI vide Circular No.2021/556, dated 29th April, 2021. We request you to take the above information on record and acknowledge the receipt of the same.

2026-05-30 12:12:49
Clarification On Price Movement

We refer to your email of 25th May, 2026 seeking clarification on your observation regarding significant movement noticed by the Exchange in the price of our company security at your exchange in the recent past. In this regard, we wish to confirm that the Company has not made any announcement (including impending announcement) nor shared any information of the significance in public domain which may have bearing on the price / volume behavior which the Exchange has not noted. The price movement is not attributable to any announcement or information shared by the Company, but is consistent with normal market behavior driven by varied external factors. However, the Company will, as a matter of practice, disclose any price sensitive information or announcement to the Exchange in compliance with applicable regulations. We therefor reiterate that the significant price movement of our company security on the Exchange is not on account of any information/announcement made by us.

2026-05-26 17:06:39

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 16.49 17.58 19.14 33.50 28.32 31.55 37.71 40.33 34.18 37.24 40.37 60.96
YOY Revenue Growth % 18.3% -8.02% 37.77% 79.57% 71.77% 79.46% 96.97% 20.36% 20.68% 18.05% 7.05% 51.16%
Other Income 0.03 0.60 2.25 2.02 2.46 1.83 2.30 3.83 2.28 2.06 2.59 1.32
Total Income 16.52 18.18 21.40 35.52 30.79 33.38 40.01 44.16 36.45 39.30 42.96 62.27
Total Expenses + 12.80 14.23 17.88 30.22 25.28 27.26 34.19 40.21 30.59 33.24 36.01 57.61
Cost of Materials Consumed 9.47 8.89 10.68 28.85 18.02 20.89 28.62 33.06 23.82 30.56 29.96 55.29
Employee Benefit Expense 2.45 2.34 1.88 1.13 2.29 1.92 2.06 2.08 2.69 1.84 2.34 1.17
Other Expenses 3.95 2.80 2.82 3.47 4.00 4.70 3.11 4.09 4.22 4.50 3.75 1.58
Operating Profit 3.69 3.35 1.26 3.28 3.04 4.29 3.52 0.12 3.59 4.00 4.35 3.35
OPM % 22.4% 19.1% 6.6% 9.8% 10.7% 13.6% 9.3% 0.3% 10.5% 10.7% 10.8% 5.5%
Profit Before Tax + 3.72 3.95 3.52 5.30 5.51 6.12 5.82 3.95 5.87 6.06 6.64 4.67
Tax Expense 0.87 0.89 0.75 0.81 0.85 0.75 0.75 0.88 0.85 0.55 0.65 0.21
Tax % 23.5% 22.4% 21.4% 15.2% 15.4% 12.3% 12.9% 22.4% 14.5% 9.1% 9.8% 4.5%
Profit After Tax 2.85 3.07 2.76 4.50 4.66 5.37 5.07 3.07 5.02 5.51 5.99 4.46
EPS (Basic) 0.16 0.17 0.16 0.16 0.21 0.21 0.22 0.13 0.22 0.21 0.22 0.16

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023
Revenue from Operations 172.74 137.90 86.71 65.60
YOY Revenue Growth % 25.26% 59.03% 32.18% -
Other Income 8.25 10.43 4.91 3.95
Total Income 180.99 148.33 91.62 69.56
Total Expenses + 157.75 126.93 75.13 63.18
Cost of Materials Consumed 139.62 100.59 57.88 46.91
Employee Benefit Expense 8.04 8.35 7.79 7.87
Other Expenses 14.34 15.90 13.04 13.12
Operating Profit 14.99 10.97 11.59 2.42
OPM % 8.7% 8% 13.4% 3.7%
Profit Before Exceptional 23.24 21.40 16.49 6.37
Exceptional Items 0.00 0.00 0.00 0.00
Profit Before Tax + 23.24 21.40 16.49 6.37
Tax Expense 2.26 3.27 3.32 1.45
Tax % 9.7% 15.3% 20.1% 22.8%
Profit After Tax 20.98 18.12 13.18 4.92
EPS (Basic) 0.76 0.79 0.67 0.35

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023
ASSETS
Non-Current Assets + 84.02 74.91 68.17 83.63
Property, Plant & Equipment 57.80 56.61 52.70 67.63
Capital Work in Progress 13.32 5.22 2.32 0.02
Non-Current Investments 0.00 0.00 0.00 0.00
Goodwill 0.00 0.00 0.00 0.00
Other Intangible Assets 2.94 2.94 2.94 6.11
Current Assets + 264.66 181.13 161.81 48.68
Inventories 53.89 35.94 25.17 15.69
Trade Receivables 43.56 14.16 17.81 9.42
Cash and Cash Equivalents 0.06 0.55 0.48 0.56
Current Investments 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 232.84 194.59 176.46 86.52
Equity Share Capital 24.29 22.74 22.74 18.02
Other Equity 198.23 163.94 147.64 62.33
Non-Current Liabilities 43.44 16.89 13.22 16.29
Current Liabilities 72.40 44.55 40.30 29.51
Total Liabilities 115.84 61.45 53.52 45.80

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023
Cash from Operating Activities -63.65 -10.80 -46.69 23.72
Cash from Investing Activities -4.80 0.82 18.91 -38.37
Cash from Financing Activities 65.30 4.57 73.68 21.03
Net Increase/Decrease in Cash -3.15 -5.41 45.91 6.38